These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10527524)

  • 1. A fluorescence-based high-performance liquid chromatographic assay to determine acid ceramidase activity.
    He X; Li CM; Park JH; Dagan A; Gatt S; Schuchman EH
    Anal Biochem; 1999 Oct; 274(2):264-9. PubMed ID: 10527524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous quantitative analysis of ceramide and sphingosine in mouse blood by naphthalene-2,3-dicarboxyaldehyde derivatization after hydrolysis with ceramidase.
    He X; Dagan A; Gatt S; Schuchman EH
    Anal Biochem; 2005 May; 340(1):113-22. PubMed ID: 15802137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [14C]ceramide synthesis by sphingolipid ceramide N-deacylase: new assay for ceramidase activity detection.
    Mitsutake S; Kita K; Okino N; Ito M
    Anal Biochem; 1997 Apr; 247(1):52-7. PubMed ID: 9126370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular analysis of acid ceramidase deficiency in patients with Farber disease.
    Bär J; Linke T; Ferlinz K; Neumann U; Schuchman EH; Sandhoff K
    Hum Mutat; 2001 Mar; 17(3):199-209. PubMed ID: 11241842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insertional mutagenesis of the mouse acid ceramidase gene leads to early embryonic lethality in homozygotes and progressive lipid storage disease in heterozygotes.
    Li CM; Park JH; Simonaro CM; He X; Gordon RE; Friedman AH; Ehleiter D; Paris F; Manova K; Hepbildikler S; Fuks Z; Sandhoff K; Kolesnick R; Schuchman EH
    Genomics; 2002 Feb; 79(2):218-24. PubMed ID: 11829492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive and reproducible fluorescent-based HPLC assay to measure the activity of acid as well as neutral beta-glucocerebrosidases.
    Hayashi Y; Zama K; Abe E; Okino N; Inoue T; Ohno K; Ito M
    Anal Biochem; 2008 Dec; 383(1):122-9. PubMed ID: 18708024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The human acid ceramidase gene (ASAH): structure, chromosomal location, mutation analysis, and expression.
    Li CM; Park JH; He X; Levy B; Chen F; Arai K; Adler DA; Disteche CM; Koch J; Sandhoff K; Schuchman EH
    Genomics; 1999 Dec; 62(2):223-31. PubMed ID: 10610716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and sensitive assay for alkaline and neutral ceramidases involving C12-NBD-ceramide.
    Tani M; Okino N; Mitsutake S; Ito M
    J Biochem; 1999 Apr; 125(4):746-9. PubMed ID: 10101288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of a novel ceramide analogue and its use in a high-throughput fluorogenic assay for ceramidases.
    Bedia C; Casas J; Garcia V; Levade T; Fabriàs G
    Chembiochem; 2007 Apr; 8(6):642-8. PubMed ID: 17361980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A high-performance liquid chromatographic assay for acid ceramidase activity in cultured fibroblasts from patients with Farber's disease and from controls.
    Mitsuo K; Kobayashi T; Shinnoh N; Goto I
    Clin Chim Acta; 1988 Apr; 173(3):281-7. PubMed ID: 3383428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic synthesis of omega-amino-ceramide: preparation of a sensitive fluorescent substrate for ceramidase.
    Tani M; Kita K; Komori H; Nakagawa T; Ito M
    Anal Biochem; 1998 Oct; 263(2):183-8. PubMed ID: 9799530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate-specificities of acid and alkaline ceramidases in fibroblasts from patients with Farber disease and controls.
    Momoi T; Ben-Yoseph Y; Nadler HL
    Biochem J; 1982 Aug; 205(2):419-25. PubMed ID: 6814427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human acid ceramidase gene: novel mutations in Farber disease.
    Zhang Z; Mandal AK; Mital A; Popescu N; Zimonjic D; Moser A; Moser H; Mukherjee AB
    Mol Genet Metab; 2000 Aug; 70(4):301-9. PubMed ID: 10993717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model SV40-transformed fibroblast lines for metabolic studies of human prosaposin and acid ceramidase deficiencies.
    Chatelut M; Harzer K; Christomanou H; Feunteun J; Pieraggi MT; Paton BC; Kishimoto Y; O'Brien JS; Basile JP; Thiers JC; Salvayre R; Levade T
    Clin Chim Acta; 1997 Jun; 262(1-2):61-76. PubMed ID: 9204210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Farber disease [Farber lipogranulomatosis], acid ceramidase deficiency].
    Koga M
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):389-93. PubMed ID: 9645089
    [No Abstract]   [Full Text] [Related]  

  • 16. Sulfatide and sphingomyelin loading of living cells as tools for the study of ceramide turnover by lysosomal ceramidase--implications for the diagnosis of Farber disease.
    Levade T; Tempesta MC; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
    Biochem Mol Med; 1995 Apr; 54(2):117-25. PubMed ID: 8581356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Farber's lipogranulomatosis].
    Koga M
    Nihon Rinsho; 1995 Dec; 53(12):3009-13. PubMed ID: 8577050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reverse activity of human acid ceramidase.
    Okino N; He X; Gatt S; Sandhoff K; Ito M; Schuchman EH
    J Biol Chem; 2003 Aug; 278(32):29948-53. PubMed ID: 12764132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and characterization of human intestinal neutral ceramidase.
    Ohlsson L; Palmberg C; Duan RD; Olsson M; Bergman T; Nilsson A
    Biochimie; 2007 Aug; 89(8):950-60. PubMed ID: 17475390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegenerative course in ceramidase deficiency (Farber disease) correlates with the residual lysosomal ceramide turnover in cultured living patient cells.
    Levade T; Moser HW; Fensom AH; Harzer K; Moser AB; Salvayre R
    J Neurol Sci; 1995 Dec; 134(1-2):108-14. PubMed ID: 8747852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.